7 medicines held by Janssen Pharmaceutica NV on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusion EU/1/22/1648/001 |
Ciltacabtagene autoleucel | Janssen Pharmaceutica NV | — |
| Opsumit 10 mg film-coated tablets EU/1/13/893/001-002 |
Macitentan | Janssen Pharmaceutica NV | — |
| Opsumit 2.5 mg film-coated tablets EU/1/13/893/004 |
Macitentan | Janssen Pharmaceutica NV | — |
| STAYVEER 125 mg film-coated tablets EU/1/13/832/002 |
Bosentan monohydrate | Janssen Pharmaceutica NV | — |
| STAYVEER 62.5 mg film-coated tablets EU/1/13/832/001 |
Bosentan monohydrate | Janssen Pharmaceutica NV | — |
| Yuvanci 10 mg/20 mg film-coated tablets EU/1/24/1859/001 |
Macitentan, Tadalafil | Janssen Pharmaceutica NV | — |
| Yuvanci 10 mg/40 mg film-coated tablets EU/1/24/1859/002 |
Macitentan, Tadalafil | Janssen Pharmaceutica NV | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.